{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:57:39Z","timestamp":1791593859923,"version":"4.3.4"},"reference-count":24,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,12]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Ravulizumab, a humanized, long-acting monoclonal antibody against complement factor C5, is a widely used treatment for paroxysmal nocturnal hemoglobinuria (PNH). Given that pregnant women with PNH are at increased risk for complications and the safety and efficacy of ravulizumab in pregnancy is not known, we performed an international multicenter retrospective analysis of 16 patients with PNH with 19 pregnancies managed with ravulizumab and compared outcomes to 8 earlier pregnancies in the same patients treated with eculizumab. Of the 8 eculizumab-treated pregnancies, 3 resulted in miscarriages and 1 in early preterm delivery for threatened fetal demise and massive fetal growth retardation. All 19 pregnancies on ravulizumab resulted in the birth of live infants, with a median gestational age of 267 days (interquartile range [IQR], 259-275) and median birth weight of 3115 g (IQR, 2458-3349). Cord blood testing in 2 pregnancies receiving intensified ravulizumab dosing revealed detectable ravulizumab levels consistent with transplacental transfer. After a median follow-up of 16.2 months (IQR, 4.4-40.1), no developmental abnormalities or severe infectious complications were observed in the children. This retrospective analysis provides evidence for the safety and effectiveness of ravulizumab in managing PNH during pregnancy and breastfeeding with favorable maternal and fetal outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025019253","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:14:26Z","timestamp":1769717666000},"page":"3067-3074","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Ravulizumab for treatment of paroxysmal nocturnal hemoglobinuria during pregnancy"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-6601","authenticated-orcid":false,"given":"Britta","family":"H\u00f6chsmann","sequence":"first","affiliation":[{"name":"1Institute of Transfusion Medicine, University of Ulm, Ulm, Germany"},{"name":"2Institute of Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service and University Hospital Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9855-0075","authenticated-orcid":false,"given":"Gloria F.","family":"Gerber","sequence":"additional","affiliation":[{"name":"3Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Leopold","sequence":"additional","affiliation":[{"name":"4Outpatient Treatment Center Oncology, Hospital Nuremberg, Nuremberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhumika J.","family":"Patel","sequence":"additional","affiliation":[{"name":"5Prisma Health Cancer Institute, Greenville, SC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8883-8208","authenticated-orcid":false,"given":"Eleni","family":"Gavriilaki","sequence":"additional","affiliation":[{"name":"62nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almut","family":"Hefter","sequence":"additional","affiliation":[{"name":"7Department of Obstetrics and Gynecology, Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Kalhammer","sequence":"additional","affiliation":[{"name":"8Hospital Group District Constance, Constance, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Opitz","sequence":"additional","affiliation":[{"name":"9DEKRA Certification GmbH, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Marx-Hoffmann","sequence":"additional","affiliation":[{"name":"1Institute of Transfusion Medicine, University of Ulm, Ulm, Germany"},{"name":"2Institute of Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service and University Hospital Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Knight","sequence":"additional","affiliation":[{"name":"5Prisma Health Cancer Institute, Greenville, SC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5741-1255","authenticated-orcid":false,"given":"Robert A.","family":"Brodsky","sequence":"additional","affiliation":[{"name":"3Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Marvaki","sequence":"additional","affiliation":[{"name":"10Department of Hematology, G Papanicolaou Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysavgi","family":"Lalayanni","sequence":"additional","affiliation":[{"name":"10Department of Hematology, G Papanicolaou Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6590-0283","authenticated-orcid":false,"given":"Sixten","family":"K\u00f6rper","sequence":"additional","affiliation":[{"name":"1Institute of Transfusion Medicine, University of Ulm, Ulm, Germany"},{"name":"2Institute of Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service and University Hospital Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1745-0353","authenticated-orcid":false,"given":"Daria V.","family":"Babushok","sequence":"additional","affiliation":[{"name":"11Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"12Division of Hematology, Department of Pediatrics, Comprehensive Bone Marrow Failure Center, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-6659","authenticated-orcid":false,"given":"Hubert","family":"Schrezenmeier","sequence":"additional","affiliation":[{"name":"1Institute of Transfusion Medicine, University of Ulm, Ulm, Germany"},{"name":"2Institute of Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service and University Hospital Ulm, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"8","key":"2026050815185339700_bib1","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","article-title":"Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories","volume":"112","author":"de Latour","year":"2008","journal-title":"Blood"},{"key":"2026050815185339700_bib2","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1038\/nrdp.2017.28","article-title":"Paroxysmal nocturnal haemoglobinuria","volume":"3","author":"Hill","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"2026050815185339700_bib3","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3324\/haematol.2010.037531","article-title":"Paroxysmal nocturnal hemoglobinuria and pregnancy before the eculizumab era: the French experience","volume":"96","author":"de Guibert","year":"2011","journal-title":"Haematologica"},{"issue":"3","key":"2026050815185339700_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0028-2243(94)90121-X","article-title":"Pregnancy and paroxysmal nocturnal hemoglobinuria","volume":"53","author":"Bais","year":"1994","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026050815185339700_bib5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1600-0412.2003.00337.x","article-title":"Paroxysmal nocturnal hemoglobinuria in pregnancy","volume":"82","author":"Bjorge","year":"2003","journal-title":"Acta Obstet.Gynecol.Scand"},{"issue":"9","key":"2026050815185339700_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.ogx.0000234794.27485.59","article-title":"Clinical management of paroxysmal nocturnal hemoglobinuria in pregnancy: a case report and updated review","volume":"61","author":"Fieni","year":"2006","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"2026050815185339700_bib7","first-page":"103","article-title":"Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient","volume":"30","author":"Ray","year":"2000","journal-title":"Haemostasis"},{"issue":"2","key":"2026050815185339700_bib8","first-page":"178","article-title":"Pregnancy with paroxysmal nocturnal hemoglobinuria: a case series with review of the literature","volume":"9","author":"Al-Dosari","year":"2021","journal-title":"J Med Med Sci"},{"issue":"11","key":"2026050815185339700_bib9","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1502950","article-title":"Eculizumab in pregnant patients with paroxysmal nocturnal hemoglobinuria","volume":"373","author":"Kelly","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"2026050815185339700_bib10","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1007\/s00277-025-06353-7","article-title":"Paroxysmal nocturnal haemoglobinuria in pregnancy-a systematic review with meta analysis","volume":"104","author":"Manning","year":"2025","journal-title":"Ann Hematol"},{"issue":"4","key":"2026050815185339700_bib11","doi-asserted-by":"crossref","first-page":"e0195909","DOI":"10.1371\/journal.pone.0195909","article-title":"Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action","volume":"13","author":"Sheridan","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"2026050815185339700_bib12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood-2018-09-876805","article-title":"Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study","volume":"133","author":"Kulasekararaj","year":"2019","journal-title":"Blood"},{"issue":"6","key":"2026050815185339700_bib13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2018-09-876136","article-title":"Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study","volume":"133","author":"Lee","year":"2019","journal-title":"Blood"},{"key":"2026050815185339700_bib14","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/bloodadvances.2018020644","article-title":"Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b\/2 studies","volume":"2","author":"Roth","year":"2018","journal-title":"Blood Adv"},{"key":"2026050815185339700_bib15","doi-asserted-by":"crossref","first-page":"2040620720966137","DOI":"10.1177\/2040620720966137","article-title":"One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria na\u00efve to complement inhibitor therapy: open-label extension of a randomized study","volume":"11","author":"Schrezenmeier","year":"2020","journal-title":"Ther Adv Hematol"},{"key":"2026050815185339700_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/bjh.16711","article-title":"Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies","volume":"191","author":"Peffault de Latour","year":"2020","journal-title":"Br J Haematol"},{"issue":"10","key":"2026050815185339700_bib17","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1182\/blood.2019003812","article-title":"How I treat paroxysmal nocturnal hemoglobinuria","volume":"137","author":"Brodsky","year":"2021","journal-title":"Blood"},{"issue":"9","key":"2026050815185339700_bib18","doi-asserted-by":"crossref","first-page":"e70278","DOI":"10.1111\/ctr.70278","article-title":"Effectiveness and safety of switching to ravulizumab from eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome: a global aHUS registry analysis","volume":"39","author":"Gaeckler","year":"2025","journal-title":"Clin Transpl"},{"issue":"2","key":"2026050815185339700_bib19","doi-asserted-by":"crossref","first-page":"e001286","DOI":"10.1136\/bmjno-2025-001286","article-title":"Transplacental transfer of ravulizumab in a pregnant woman with neuromyelitis optica: a case report","volume":"7","author":"Jacob","year":"2025","journal-title":"BMJ Neurol Open"},{"issue":"2","key":"2026050815185339700_bib20","first-page":"e54207","article-title":"Pregnancy-associated atypical hemolytic uremic syndrome successfully treated with ravulizumab: a case report","volume":"16","author":"Miyazaki","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"2026050815185339700_bib21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3324\/haematol.2019.236877","article-title":"Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Brodsky","year":"2021","journal-title":"Haematologica"},{"issue":"12","key":"2026050815185339700_bib22","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/ndt\/gfw314","article-title":"Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab","volume":"31","author":"Servais","year":"2016","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"2026050815185339700_bib23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/blood-2014-03-560540","article-title":"Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab","volume":"125","author":"Peffault de Latour","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2026050815185339700_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.imbio.2014.11.003","article-title":"Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn","volume":"220","author":"Hallstensen","year":"2015","journal-title":"Immunobiology"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/9\/3067\/2516192\/blooda_adv-2025-019253-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/9\/3067\/2516192\/blooda_adv-2025-019253-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:18:59Z","timestamp":1778267939000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/9\/3067\/566331\/Ravulizumab-for-treatment-of-paroxysmal-nocturnal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,5,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025019253","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,12]]},"published":{"date-parts":[[2026,5,1]]}}}